Speciality: Hematology
Description:
Welcome to our podcast on Innovations in Hematology. Over the past decade, advances in this field have transformed the diagnosis and treatment of blood disorders. From next-generation sequencing that helps identify genetic mutations, to targeted therapies for conditions like leukemia and lymphoma, patients now have more personalized treatment options than ever before. Stem cell transplants and gene editing techniques, such as CRISPR, offer hope for curing previously incurable diseases. Artificial intelligence is also playing a role, improving diagnostic accuracy and helping doctors make better decisions. As research continues, the future of hematology looks promising, bringing new possibilities for patients and clinicians alike.
See More Webinars @ Hidoc Webinars
1.
Why alarm is easing over a rise in pancreatic cancer among the young
2.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
3.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
4.
For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
3.
Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts
4.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
5.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation